Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Sanofi-Synthelabo submits MAA for Ditropan XL in the U.K.

Aug. 16, 1999

Leading BPH treatment to be copromoted by Abbott and Boehringer Ingelheim

Aug. 16, 1999

NexMed reports results from multiple-use study of topical alprostadil cream

Aug. 16, 1999

NIH initiates interstitial cystitis trial

Aug. 16, 1999

Phase II testing of Alexion's C5 complement inhibitor also begins in renal diseases

Aug. 12, 1999

FDA puts hold on clinical study of Vasomax

Aug. 12, 1999

BioSpecifics Technologies announces positive preliminary results in Peyronie's disease therapy

Aug. 11, 1999

Mochida presents potent and selective heterocyclic cGMP-PDE inhibitors

July 30, 1999

NS-49: preclinical pharmacokinetics of potential new agent for stress incontinence

July 28, 1999

Rochester Medical's female incontinence device receives CE mark

July 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...